Business Information
The group's principal activity is to develop, manufacture and market jet injection systems for needle-free drug administration. The technology allows healthcare professionals to inject medications through the skin, both intramuscularly and subcutaneously without the risk of needlestick injuries and blood-borne pathogen transmission. Bioject(R) is a hand-held and reusable jet injector and a sterile, single-use, disposable plastic syringe. Vitajet(R) is a spring-powered, needle-free and self-injection device. The products are sold directly to healthcare providers and are licensed to pharmaceutical and biotechnology companies.
|
|
Name |
Title
|
Email
|
| Jerald Cobbs | Chmn., Interim Pres. | N/A | | Ralph Makar | CEO, Pres. | N/A | | Christine Farrell | VP - Administration, Controller - Principal Financial, Accounting Officer | N/A | | Richard Stout | VP - Clinical Affairs | N/A | | Brigid Makes | Dir. | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 10,795 | (6,997) | | 2005 | 12,288 | (6,589) | | 2004 | 9,486 | (9,081)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
